Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer (2018) Golfmann K, Meder L, Koker M, Volz C, Borchmann S, Tharun L, Dietlein F, et al. Journal article LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy (2018) Rossow L, Veitl S, Vorlova S, Wax JK, Kuhn AE, Maltzahn V, Upcin B, et al. Journal article LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model (2018) Meder L, Koenig K, Dietlein F, Macheleidt I, Florin A, Ercanoglu MS, Rommerscheidt-Fuss U, et al. Journal article RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas (2018) Kunz M, Loeffler-Wirth H, Dannemann M, Willscher E, Doose G, Kelso J, Kottek T, et al. Journal article Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors (2018) Sirtl S, Knoll G, Dieu Thuy Trinh , Lang I, Siegmund D, Gross S, Schuler-Thurner B, et al. Journal article ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner (2017) Chen D, Fan Z, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N Journal article GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers (2017) Rasheed SAK, Leong HS, Lakshmanan M, Raju A, Dadlani D, Chong FT, Shannon NB, et al. Journal article The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma (2017) Hermanns C, Hampl V, Holzer K, Aigner A, Penkava J, Frank N, Martin DE, et al. Journal article Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition (2017) Dietrich P, Kuphal S, Spruss T, Hellerbrand C, Boßerhoff AK Journal article The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation (2017) Maurus K, Hufnagel A, Geiger F, Graf S, Berking C, Heinemann A, Paschen A, et al. Journal article